BIOMARIN PHARMACEUTICAL INC Capital Expenditures
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Capital Expenditures of $49.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $28.82M, a 68.50% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $20.92M, a 24.78% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $40.72M, a 108.51% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $28.45M, a 54.08% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for fiscal 2025 was $103.04M, a 20.62% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for fiscal 2024 was $85.42M, a 11.65% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for fiscal 2023 was $96.69M, a 20.06% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC payments to acquire property, plant, and equipment for fiscal 2022 was $120.96M, a 26.56% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 1 month | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $49.74M 10-Q · filed 2026-08-06 | $90.46M derived: sum of 3 quarters · filed 2026-08-06 | $118.91M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $20.92M 10-Q · filed 2026-05-05 | $61.65M derived: sum of 2 quarters · filed 2026-05-05 | $90.09M derived: sum of 3 quarters · filed 2026-05-05 | $107.19M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $40.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $69.17M derived: sum of 2 quarters · filed 2026-02-26 | $86.27M derived: sum of 3 quarters · filed 2026-08-06 | $103.04M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $28.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $45.55M derived: sum of 2 quarters · filed 2026-08-06 | $62.32M 10-Q · filed 2025-10-28 | $81.85M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $17.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $33.87M 10-Q · filed 2026-08-06 | $53.40M derived: sum of 3 quarters · filed 2026-08-06 | $71.86M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | $16.77M 10-Q · filed 2026-05-05 | $36.30M derived: sum of 2 quarters · filed 2026-05-05 | $54.76M derived: sum of 3 quarters · filed 2026-05-05 | $76.09M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2024-12-31 | $19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.99M derived: sum of 2 quarters · filed 2026-02-26 | $59.32M derived: sum of 3 quarters · filed 2026-02-26 | $85.42M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $18.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $39.79M derived: sum of 2 quarters · filed 2025-10-28 | $65.89M 10-Q · filed 2025-10-28 | $94.81M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-06-30 | $21.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $47.43M 10-Q · filed 2025-08-05 | $76.35M derived: sum of 3 quarters · filed 2026-02-26 | $98.08M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | $26.10M 10-Q · filed 2025-05-02 | $55.02M derived: sum of 2 quarters · filed 2026-02-26 | $76.76M derived: sum of 3 quarters · filed 2026-02-26 | $98.34M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | $28.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $50.65M derived: sum of 2 quarters · filed 2026-02-26 | $72.23M derived: sum of 3 quarters · filed 2026-02-26 | $96.69M 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $21.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $43.32M derived: sum of 2 quarters · filed 2024-10-31 | $67.77M 10-Q · filed 2024-10-31 | $103.46M derived: sum of 4 quarters · filed 2025-02-24 | |||||
| 2023-06-30 | $21.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $46.04M 10-Q · filed 2024-08-05 | $81.73M derived: sum of 3 quarters · filed 2025-02-24 | $111.03M derived: sum of 4 quarters · filed 2025-02-24 | |||||
| 2023-03-31 | $24.46M 10-Q · filed 2024-04-26 | $60.14M derived: sum of 2 quarters · filed 2025-02-24 | $89.44M derived: sum of 3 quarters · filed 2025-02-24 | $116.60M derived: sum of 4 quarters · filed 2025-02-24 | |||||
| 2022-12-31 | $35.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $64.99M derived: sum of 2 quarters · filed 2025-02-24 | $92.14M derived: sum of 3 quarters · filed 2025-02-24 | $120.96M 10-K · filed 2025-02-24 | |||||
| 2022-09-30 | $29.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $56.45M derived: sum of 2 quarters · filed 2023-11-02 | $85.27M 10-Q · filed 2023-11-02 | $114.01M derived: sum of 4 quarters · filed 2024-02-26 | |||||
| 2022-06-30 | $27.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $55.97M 10-Q · filed 2023-08-02 | $84.71M derived: sum of 3 quarters · filed 2024-02-26 | $103.44M derived: sum of 4 quarters · filed 2024-02-26 | |||||
| 2022-03-31 | $28.82M 10-Q · filed 2023-04-28 | $57.55M derived: sum of 2 quarters · filed 2024-02-26 | $76.29M derived: sum of 3 quarters · filed 2024-02-26 | $98.89M derived: sum of 4 quarters · filed 2024-02-26 | |||||
| 2021-12-31 | $28.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $47.47M derived: sum of 2 quarters · filed 2024-02-26 | $70.07M derived: sum of 3 quarters · filed 2024-02-26 | $95.58M 10-K · filed 2024-02-26 | |||||
| 2021-09-30 | $18.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $41.33M derived: sum of 2 quarters · filed 2022-10-28 | $66.84M 10-Q · filed 2022-10-28 | $97.87M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2021-06-30 | $22.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $48.11M 10-Q · filed 2022-08-04 | $79.13M derived: sum of 3 quarters · filed 2023-02-27 | $95.70M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2021-03-31 | $25.51M 10-Q · filed 2022-04-29 | $56.53M derived: sum of 2 quarters · filed 2023-02-27 | $73.10M derived: sum of 3 quarters · filed 2023-02-27 | $99.27M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2020-12-31 | $31.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $47.60M derived: sum of 2 quarters · filed 2023-02-27 | $73.76M derived: sum of 3 quarters · filed 2023-02-27 | $114.31M 10-K · filed 2023-02-27 | |||||
| 2020-09-30 | $16.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $42.73M derived: sum of 2 quarters · filed 2021-10-29 | $83.29M 10-Q · filed 2021-10-29 | $134.07M derived: sum of 4 quarters · filed 2022-02-25 | |||||
| 2020-06-30 | $26.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $66.72M 10-Q · filed 2021-07-30 | $117.50M derived: sum of 3 quarters · filed 2022-02-25 | $150.35M derived: sum of 4 quarters · filed 2022-02-25 | |||||
| 2020-03-31 | $40.55M 10-Q · filed 2021-04-30 | $91.34M derived: sum of 2 quarters · filed 2022-02-25 | $124.19M derived: sum of 3 quarters · filed 2022-02-25 | $156.82M derived: sum of 4 quarters · filed 2022-02-25 | |||||
| 2019-12-31 | $50.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $83.64M derived: sum of 2 quarters · filed 2022-02-25 | $116.27M derived: sum of 3 quarters · filed 2022-02-25 | $145.03M 10-K · filed 2022-02-25 | |||||
| 2019-09-30 | $32.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $65.48M derived: sum of 2 quarters · filed 2020-11-06 | $94.24M 10-Q · filed 2020-11-06 | $136.32M derived: sum of 4 quarters · filed 2021-02-26 | |||||
| 2019-06-30 | $32.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $61.39M 10-Q · filed 2020-08-05 | $103.47M derived: sum of 3 quarters · filed 2021-02-26 | $153.32M derived: sum of 4 quarters · filed 2021-02-26 | |||||
| 2019-03-31 | $28.76M 10-Q · filed 2020-05-01 | $70.83M derived: sum of 2 quarters · filed 2021-02-26 | $120.69M derived: sum of 3 quarters · filed 2021-02-26 | $143.21M derived: sum of 4 quarters · filed 2021-02-26 | |||||
| 2018-12-31 | $42.08M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $91.94M derived: sum of 2 quarters · filed 2021-02-26 | $114.46M derived: sum of 3 quarters · filed 2021-02-26 | $144.62M 10-K · filed 2021-02-26 | |||||
| 2018-09-30 | $49.86M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | $72.38M derived: sum of 2 quarters · filed 2019-11-04 | $102.54M 10-Q/A · filed 2019-11-04 | $142.43M derived: sum of 4 quarters · filed 2020-02-27 | |||||
| 2018-06-30 | $22.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $52.68M 10-Q · filed 2019-08-02 | $92.57M derived: sum of 3 quarters · filed 2020-02-27 | $135.05M derived: sum of 4 quarters · filed 2020-02-27 | |||||
| 2018-03-31 | $30.16M 10-Q · filed 2019-04-29 | $70.05M derived: sum of 2 quarters · filed 2020-02-27 | $112.54M derived: sum of 3 quarters · filed 2020-02-27 | $160.29M derived: sum of 4 quarters · filed 2020-02-27 | |||||
| 2017-12-31 | $39.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $82.37M derived: sum of 2 quarters · filed 2020-02-27 | $130.13M derived: sum of 3 quarters · filed 2020-02-27 | $199.22M 10-K · filed 2020-02-27 | |||||
| 2017-09-30 | $42.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $90.24M derived: sum of 2 quarters · filed 2018-10-26 | $159.33M 10-Q · filed 2018-10-26 | $210.90M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-06-30 | $47.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $116.85M 10-Q · filed 2018-08-03 | $168.42M derived: sum of 3 quarters · filed 2019-02-28 | $194.52M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-03-31 | $69.09M 10-Q · filed 2018-04-27 | $120.66M derived: sum of 2 quarters · filed 2019-02-28 | $146.76M derived: sum of 3 quarters · filed 2019-02-28 | $172.27M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2016-12-31 | $51.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $77.67M derived: sum of 2 quarters · filed 2019-02-28 | $103.18M derived: sum of 3 quarters · filed 2019-02-28 | $148.38M 10-K · filed 2019-02-28 | |||||
| 2016-09-30 | $26.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $51.60M derived: sum of 2 quarters · filed 2017-10-31 | $96.81M 10-Q · filed 2017-10-31 | $200.62M derived: sum of 4 quarters · filed 2018-02-26 | |||||
| 2016-06-30 | $25.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $70.71M 10-Q · filed 2017-08-02 | $174.52M derived: sum of 3 quarters · filed 2018-02-26 | $219.07M derived: sum of 4 quarters · filed 2018-02-26 | |||||
| 2016-03-31 | $45.20M 10-Q · filed 2017-05-04 | $149.01M derived: sum of 2 quarters · filed 2018-02-26 | $193.57M derived: sum of 3 quarters · filed 2018-02-26 | $229.03M derived: sum of 4 quarters · filed 2018-02-26 | |||||
| 2015-12-31 | $103.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $148.37M derived: sum of 2 quarters · filed 2018-02-26 | $183.82M derived: sum of 3 quarters · filed 2018-02-26 | $227.65M 10-K · filed 2018-02-26 | |||||
| 2015-09-30 | $44.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $80.01M derived: sum of 2 quarters · filed 2016-11-03 | $123.84M 10-Q · filed 2016-11-03 | $151.61M derived: sum of 4 quarters · filed 2017-02-27 | |||||
| 2015-06-30 | $35.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $79.29M 10-Q · filed 2016-08-08 | $107.06M derived: sum of 3 quarters · filed 2017-02-27 | $132.22M derived: sum of 4 quarters · filed 2017-02-27 | |||||
| 2015-03-31 | $43.83M 10-Q · filed 2016-05-02 | $71.60M derived: sum of 2 quarters · filed 2017-02-27 | $96.77M derived: sum of 3 quarters · filed 2017-02-27 | $116.77M derived: sum of 4 quarters · filed 2017-02-27 | |||||
| 2014-12-31 | $27.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $52.94M derived: sum of 2 quarters · filed 2017-02-27 | $72.94M derived: sum of 3 quarters · filed 2017-02-27 | $117.06M 10-K · filed 2017-02-27 | $118.83M 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | $25.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $45.17M derived: sum of 2 quarters · filed 2015-11-02 | $89.30M 10-Q · filed 2015-11-02 | $89.63M 10-Q · filed 2014-10-28 | $98.53M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $20.00M 10-Q · filed 2014-07-31 | $64.13M 10-Q · filed 2015-08-05 | $64.71M 10-Q · filed 2014-07-31 | $73.36M derived: sum of 3 quarters · filed 2016-02-29 | $86.56M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $23.61M 10-Q · filed 2015-05-05 | $24.18M 10-Q · filed 2014-05-02 | $53.36M derived: sum of 2 quarters · filed 2016-02-29 | $66.56M derived: sum of 3 quarters · filed 2016-02-29 | $76.97M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $29.75M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $42.95M derived: sum of 2 quarters · filed 2016-02-29 | $53.37M derived: sum of 3 quarters · filed 2016-02-29 | $65.19M 10-K · filed 2016-02-29 | $65.12M 10-K · filed 2014-02-26 | ||||
| 2013-09-30 | $13.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $23.61M derived: sum of 2 quarters · filed 2014-10-28 | $35.44M 10-Q · filed 2014-10-28 | $49.34M derived: sum of 4 quarters · filed 2015-03-02 | |||||
| 2013-06-30 | $10.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $22.24M 10-Q · filed 2014-07-31 | $36.13M derived: sum of 3 quarters · filed 2015-03-02 | $51.15M derived: sum of 4 quarters · filed 2015-03-02 | |||||
| 2013-03-31 | $11.83M 10-Q · filed 2014-05-02 | $25.72M derived: sum of 2 quarters · filed 2015-03-02 | $40.73M derived: sum of 3 quarters · filed 2015-03-02 | $50.22M derived: sum of 4 quarters · filed 2015-03-02 | |||||
| 2012-12-31 | $13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $28.91M derived: sum of 2 quarters · filed 2015-03-02 | $38.39M derived: sum of 3 quarters · filed 2015-03-02 | $44.57M 10-K · filed 2015-03-02 | |||||
| 2012-09-30 | $15.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $24.50M derived: sum of 2 quarters · filed 2013-10-28 | $30.68M 10-Q · filed 2013-10-28 | $39.36M derived: sum of 4 quarters · filed 2014-02-26 | |||||
| 2012-06-30 | $9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $15.66M 10-Q · filed 2013-07-29 | $24.34M derived: sum of 3 quarters · filed 2014-02-26 | $80.73M derived: sum of 4 quarters · filed 2014-02-26 | |||||
| 2012-03-31 | $6.18M 10-Q · filed 2013-04-29 | $14.86M derived: sum of 2 quarters · filed 2014-02-26 | $71.25M derived: sum of 3 quarters · filed 2014-02-26 | $73.16M derived: sum of 4 quarters · filed 2014-02-26 | |||||
| 2011-12-31 | $8.68M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $65.07M derived: sum of 2 quarters · filed 2014-02-26 | $66.98M derived: sum of 3 quarters · filed 2014-02-26 | $73.22M 10-K · filed 2014-02-26 | |||||
| 2011-09-30 | $56.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $58.30M derived: sum of 2 quarters · filed 2012-10-29 | $64.54M 10-Q · filed 2012-10-29 | $75.28M derived: sum of 4 quarters · filed 2013-02-26 | |||||
| 2011-08-31 | $49.67M 10-Q · filed 2011-10-31 | ||||||||
| 2011-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $8.15M 10-Q · filed 2012-08-02 | $18.89M derived: sum of 3 quarters · filed 2013-02-26 | $28.26M derived: sum of 4 quarters · filed 2013-02-26 | |||||
| 2011-03-31 | $6.24M 10-Q · filed 2012-04-30 | $16.98M derived: sum of 2 quarters · filed 2013-02-26 | $26.35M derived: sum of 3 quarters · filed 2013-02-26 | $41.59M derived: sum of 4 quarters · filed 2013-02-26 | |||||
| 2010-12-31 | $10.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $20.11M derived: sum of 2 quarters · filed 2013-02-26 | $35.35M derived: sum of 3 quarters · filed 2013-02-26 | $49.46M 10-K · filed 2013-02-26 | |||||
| 2010-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $24.61M derived: sum of 2 quarters · filed 2011-10-31 | $38.72M 10-Q · filed 2011-10-31 | $61.34M derived: sum of 4 quarters · filed 2012-02-22 | |||||
| 2010-06-30 | $15.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $29.35M 10-Q · filed 2011-08-01 | $51.97M derived: sum of 3 quarters · filed 2012-02-22 | $78.53M derived: sum of 4 quarters · filed 2012-02-22 | |||||
| 2010-03-31 | $14.11M 10-Q · filed 2011-04-29 | $36.73M derived: sum of 2 quarters · filed 2012-02-22 | $63.29M derived: sum of 3 quarters · filed 2012-02-22 | ||||||
| 2009-12-31 | $22.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $49.18M derived: sum of 2 quarters · filed 2012-02-22 | $89.80M 10-K · filed 2012-02-22 | ||||||
| 2009-09-30 | $26.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $67.18M 10-Q · filed 2010-10-29 | |||||||
| 2009-06-30 | $40.62M 10-Q · filed 2010-08-04 | ||||||||
| 2008-12-31 | $56.37M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |